Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18F-FDG PET study

✍ Scribed by Eugenii A. Rabiner; Sofia Tzimopoulou; Vincent J. Cunningham; Barbara Jeter; Marina Zvartau-Hind; Mary Castiglia; Praful Mistry; Nick P. Bird; Julian Matthews; Brandon Whitcher; Thomas E. Nichols; Robert Lai; Narinder Lotay; Ann Saunders; Eric Reiman; Kewei Chen; Mike Gold; Paul M. Matthews

• Book ID: 118465631
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 62 KB
• Volume: 5
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2009.05.642